{"id":66593,"date":"2022-10-03T12:08:08","date_gmt":"2022-10-03T10:08:08","guid":{"rendered":"http:\/\/www.veeva.com\/eu\/?p=66593"},"modified":"2026-02-23T20:31:13","modified_gmt":"2026-02-23T19:31:13","slug":"4-tips-to-streamline-content-review-and-approval","status":"publish","type":"post","link":"https:\/\/www.veeva.com\/eu\/blog\/4-tips-to-streamline-content-review-and-approval\/","title":{"rendered":"4 Tips to Streamline Content Review and Approval"},"content":{"rendered":"<p>According to Veeva data, most biopharmas take <a href=\"https:\/\/www.veeva.com\/eu\/resources\/higher-content-volumes-make-benchmarking-vital\/\" title=\"Higher Content Volumes Make Benchmarking Vital\">three weeks<\/a> to deliver new content to market. At Amylyx, we\u2019ve been focusing on preparing for our drug launch \u2014 and ensuring a strong foundation for content creation that will scale as the company grows has been one of my top priorities. Here are four tips to streamline your medical, legal, and regulatory (MLR) operations, based on our recent efforts to do this.<\/p>\n<h2>1. Set the right foundation to scale<\/h2>\n<p>The first step is to define what &#8216;good&#8217; looks like by getting cross-functional alignment on common goals, including a brand strategy, resource needs, and process. Challenge your cross-functional team by asking questions such as, \u201chow long should this take?\u201d or \u201cwho needs a seat at the table?\u201d I recommend waiting to implement a platform solution until stakeholders fully understand their requirements to set the proper foundation for the team.<\/p>\n<p>Gaining stakeholder alignment will also help streamline change management. It\u2019s critical for stakeholders to know what they want and need and then build the right foundation based on your organization&#8217;s requirements. This approach worked very well for us and optimized our implementation with <a href=\"\/eu\/products\/vault-promomats\/\">Veeva PromoMats<\/a>.<\/p>\n<h2>2. Leverage technology at the right time<\/h2>\n<p>Having a content management solution in place before launch is essential, but the exact timing of implementing a solution will depend on your organization. I look at two markers to determine the proper timing:<\/p>\n<ol>\n<li><strong>When the review cycle becomes a pain point.<\/strong> If the MLR team is experiencing confusion, there are version control issues, or the process is taking too long, it&#8217;s probably time to explore technology solutions that can help.<\/li>\n<li><strong>When bandwidth or resourcing issues surface.<\/strong> If the content owner is struggling to keep up with the org&#8217;s growing content volume, implementing technology to help automate processes will enable the team to move faster.<\/li>\n<\/ol>\n<h2>3. Introduce \u201cMLR Step Zero\u201d into your process<\/h2>\n<p>Content owners often feel that the end-to-end content process takes too long, from concept to approval. Typically, several precursory reviews need to happen before a document reaches the MLR committee, and there\u2019s still the risk of additional cycles from MLR teams. MLR Step Zero takes place before MLR meetings so internal and agency stakeholders can agree on timelines, goals, and the overall process early on. Consider meeting stakeholders to review concepts before you start to build your promotional materials. This approach enables content owners to understand sensitivities upfront and have a better framework to drive the content process, ultimately reducing the number of reviews.<\/p>\n<p>MLR Step Zero is all about streamlining the pre-MLR process. Typically, teams develop materials with multiple stakeholders\u2019 input resulting in many reviews before it even gets to MLR. I always recommend leveraging concept reviews during MLR meetings, but you can use a similar process outside of MLR to gain other stakeholders\u2019 buy-in. Consider setting up a meeting with all non-MLR stakeholders to ensure alignment on the process, timing, objectives, and \u201cneed to haves\u201d versus \u201cnice to haves.\u201d<\/p>\n<p>This approach also ensures a clear concept review for reviewers during MLR. When content owners and stakeholders align, it ultimately reduces the number of reviews and keeps the process running smoothly.<\/p>\n<h2>4. Be consistent with MLR review timelines<\/h2>\n<p>There\u2019s more consistency and less frustration when stakeholders are clear about deadlines for content review. For example, we set the following schedule: content submission by Wednesday at 4 p.m., and reviewers\u2019 comments are due by the following Wednesday at 4 p.m. Content owners have until 4 p.m. on Thursday (24 hours) to respond to comments in time for the weekly MLR meetings. By being consistent, stakeholders can work toward the same timeline and structure.<\/p>\n<p>To reinforce these timelines, I established a weekly forecasting meeting with content owners and initiators (agency), which also serves as an open forum to address any timing or prioritization efforts needed. I scheduled this meeting at the submission deadline to accurately collect submissions for the following week\u2019s review and the MLR agenda for the next day.<\/p>\n<p>Overall, the key to streamlining the MLR process is establishing open communications, setting the right expectations for consistency, and building a solid foundation to enable teams.<\/p>\n<p>Watch the on-demand <a href=\"\/eu\/customer-stories\/amylyx-streamlining-mlr-operations\/\">emerging biopharma leader spotlight session<\/a> to learn more about how to streamline your MLR operations.<\/p>\n<p><em><em><strong>The elements presented here are the views and opinions of Jacci Lufkin and do not necessarily represent those of Amylyx.<\/strong><\/em><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>According to Veeva Pulse data, most biopharmas take three weeks to deliver new content to market. At Amylyx, we\u2019ve been focusing on preparing for our drug launch \u2014 and ensuring a strong foundation for content creation that will scale as the company grows has been one of my top priorities.<\/p>\n","protected":false},"author":80,"featured_media":66599,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_members_access_role":[],"_members_access_error":""},"categories":[1],"tags":[],"product":[996],"area":[972],"coauthors":[1587],"class_list":["post-66593","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","product-commercial-content-promomats","area-commercial"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO Pro 5.0.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"According to Veeva Pulse data, most biopharmas take three weeks to deliver new content to market. At Amylyx, we\u2019ve been focusing on preparing for our drug launch \u2014 and ensuring a strong foundation for content creation that will scale as the company grows has been one of my top priorities.\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.veeva.com\/eu\/blog\/4-tips-to-streamline-content-review-and-approval\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO Pro (AIOSEO) 5.0.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Veeva Systems Europe\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"4 Tips to Streamline Content Review and Approval | Veeva Systems Europe\" \/>\n\t\t<meta property=\"og:description\" content=\"According to Veeva Pulse data, most biopharmas take three weeks to deliver new content to market. At Amylyx, we\u2019ve been focusing on preparing for our drug launch \u2014 and ensuring a strong foundation for content creation that will scale as the company grows has been one of my top priorities.\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.veeva.com\/eu\/blog\/4-tips-to-streamline-content-review-and-approval\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/www.veeva.com\/eu\/wp-content\/uploads\/2026\/08\/web-default-featured-image-1200x630-2@2x.jpg\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/www.veeva.com\/eu\/wp-content\/uploads\/2026\/08\/web-default-featured-image-1200x630-2@2x.jpg\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2022-10-03T10:08:08+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-02-23T19:31:13+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"4 Tips to Streamline Content Review and Approval | Veeva Systems Europe\" \/>\n\t\t<meta name=\"twitter:description\" content=\"According to Veeva Pulse data, most biopharmas take three weeks to deliver new content to market. At Amylyx, we\u2019ve been focusing on preparing for our drug launch \u2014 and ensuring a strong foundation for content creation that will scale as the company grows has been one of my top priorities.\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/www.veeva.com\/eu\/wp-content\/uploads\/2026\/08\/web-default-featured-image-1200x630-2@2x.jpg\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/blog\\\/4-tips-to-streamline-content-review-and-approval\\\/#article\",\"name\":\"4 Tips to Streamline Content Review and Approval | Veeva Systems Europe\",\"headline\":\"4 Tips to Streamline Content Review and Approval\",\"author\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/author\\\/jacci-lufkin\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/wp-content\\\/uploads\\\/2022\\\/09\\\/Jacci-Lufkin_300x300.jpeg\",\"width\":300,\"height\":300},\"datePublished\":\"2022-10-03T12:08:08+02:00\",\"dateModified\":\"2026-02-23T20:31:13+01:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/blog\\\/4-tips-to-streamline-content-review-and-approval\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/blog\\\/4-tips-to-streamline-content-review-and-approval\\\/#webpage\"},\"articleSection\":\"Uncategorized, Commercial Content (PromoMats), Commercial, jacci-lufkin\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/blog\\\/4-tips-to-streamline-content-review-and-approval\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.veeva.com\\\/eu\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/category\\\/uncategorized\\\/#listItem\",\"name\":\"Uncategorized\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/category\\\/uncategorized\\\/#listItem\",\"position\":2,\"name\":\"Uncategorized\",\"item\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/category\\\/uncategorized\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/blog\\\/4-tips-to-streamline-content-review-and-approval\\\/#listItem\",\"name\":\"4 Tips to Streamline Content Review and Approval\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/blog\\\/4-tips-to-streamline-content-review-and-approval\\\/#listItem\",\"position\":3,\"name\":\"4 Tips to Streamline Content Review and Approval\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/category\\\/uncategorized\\\/#listItem\",\"name\":\"Uncategorized\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/#organization\",\"name\":\"Veeva Systems Europe\",\"description\":\"EU Site\",\"url\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/author\\\/jacci-lufkin\\\/#author\",\"url\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/author\\\/jacci-lufkin\\\/\",\"name\":\"Jacci Lufkin\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/blog\\\/4-tips-to-streamline-content-review-and-approval\\\/#webpage\",\"url\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/blog\\\/4-tips-to-streamline-content-review-and-approval\\\/\",\"name\":\"4 Tips to Streamline Content Review and Approval | Veeva Systems Europe\",\"description\":\"According to Veeva Pulse data, most biopharmas take three weeks to deliver new content to market. At Amylyx, we\\u2019ve been focusing on preparing for our drug launch \\u2014 and ensuring a strong foundation for content creation that will scale as the company grows has been one of my top priorities.\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/blog\\\/4-tips-to-streamline-content-review-and-approval\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/author\\\/jacci-lufkin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/author\\\/jacci-lufkin\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/wp-content\\\/uploads\\\/2022\\\/09\\\/Jacci-Lufkin_300x300.jpeg\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/blog\\\/4-tips-to-streamline-content-review-and-approval\\\/#mainImage\",\"width\":300,\"height\":300},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/blog\\\/4-tips-to-streamline-content-review-and-approval\\\/#mainImage\"},\"datePublished\":\"2022-10-03T12:08:08+02:00\",\"dateModified\":\"2026-02-23T20:31:13+01:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/#website\",\"url\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/\",\"name\":\"Veeva Systems Europe\",\"description\":\"EU Site\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO Pro -->\r\n\t\t<title>4 Tips to Streamline Content Review and Approval | Veeva Systems Europe<\/title>\n\n","aioseo_head_json":{"title":"4 Tips to Streamline Content Review and Approval | Veeva Systems Europe","description":"According to Veeva Pulse data, most biopharmas take three weeks to deliver new content to market. At Amylyx, we\u2019ve been focusing on preparing for our drug launch \u2014 and ensuring a strong foundation for content creation that will scale as the company grows has been one of my top priorities.","canonical_url":"https:\/\/www.veeva.com\/eu\/blog\/4-tips-to-streamline-content-review-and-approval\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.veeva.com\/eu\/blog\/4-tips-to-streamline-content-review-and-approval\/#article","name":"4 Tips to Streamline Content Review and Approval | Veeva Systems Europe","headline":"4 Tips to Streamline Content Review and Approval","author":{"@id":"https:\/\/www.veeva.com\/eu\/author\/jacci-lufkin\/#author"},"publisher":{"@id":"https:\/\/www.veeva.com\/eu\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/www.veeva.com\/eu\/wp-content\/uploads\/2022\/09\/Jacci-Lufkin_300x300.jpeg","width":300,"height":300},"datePublished":"2022-10-03T12:08:08+02:00","dateModified":"2026-02-23T20:31:13+01:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/www.veeva.com\/eu\/blog\/4-tips-to-streamline-content-review-and-approval\/#webpage"},"isPartOf":{"@id":"https:\/\/www.veeva.com\/eu\/blog\/4-tips-to-streamline-content-review-and-approval\/#webpage"},"articleSection":"Uncategorized, Commercial Content (PromoMats), Commercial, jacci-lufkin"},{"@type":"BreadcrumbList","@id":"https:\/\/www.veeva.com\/eu\/blog\/4-tips-to-streamline-content-review-and-approval\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/eu#listItem","position":1,"name":"Home","item":"https:\/\/www.veeva.com\/eu","nextItem":{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/eu\/category\/uncategorized\/#listItem","name":"Uncategorized"}},{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/eu\/category\/uncategorized\/#listItem","position":2,"name":"Uncategorized","item":"https:\/\/www.veeva.com\/eu\/category\/uncategorized\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/eu\/blog\/4-tips-to-streamline-content-review-and-approval\/#listItem","name":"4 Tips to Streamline Content Review and Approval"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/eu#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/eu\/blog\/4-tips-to-streamline-content-review-and-approval\/#listItem","position":3,"name":"4 Tips to Streamline Content Review and Approval","previousItem":{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/eu\/category\/uncategorized\/#listItem","name":"Uncategorized"}}]},{"@type":"Organization","@id":"https:\/\/www.veeva.com\/eu\/#organization","name":"Veeva Systems Europe","description":"EU Site","url":"https:\/\/www.veeva.com\/eu\/"},{"@type":"Person","@id":"https:\/\/www.veeva.com\/eu\/author\/jacci-lufkin\/#author","url":"https:\/\/www.veeva.com\/eu\/author\/jacci-lufkin\/","name":"Jacci Lufkin"},{"@type":"WebPage","@id":"https:\/\/www.veeva.com\/eu\/blog\/4-tips-to-streamline-content-review-and-approval\/#webpage","url":"https:\/\/www.veeva.com\/eu\/blog\/4-tips-to-streamline-content-review-and-approval\/","name":"4 Tips to Streamline Content Review and Approval | Veeva Systems Europe","description":"According to Veeva Pulse data, most biopharmas take three weeks to deliver new content to market. At Amylyx, we\u2019ve been focusing on preparing for our drug launch \u2014 and ensuring a strong foundation for content creation that will scale as the company grows has been one of my top priorities.","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/www.veeva.com\/eu\/#website"},"breadcrumb":{"@id":"https:\/\/www.veeva.com\/eu\/blog\/4-tips-to-streamline-content-review-and-approval\/#breadcrumblist"},"author":{"@id":"https:\/\/www.veeva.com\/eu\/author\/jacci-lufkin\/#author"},"creator":{"@id":"https:\/\/www.veeva.com\/eu\/author\/jacci-lufkin\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/www.veeva.com\/eu\/wp-content\/uploads\/2022\/09\/Jacci-Lufkin_300x300.jpeg","@id":"https:\/\/www.veeva.com\/eu\/blog\/4-tips-to-streamline-content-review-and-approval\/#mainImage","width":300,"height":300},"primaryImageOfPage":{"@id":"https:\/\/www.veeva.com\/eu\/blog\/4-tips-to-streamline-content-review-and-approval\/#mainImage"},"datePublished":"2022-10-03T12:08:08+02:00","dateModified":"2026-02-23T20:31:13+01:00"},{"@type":"WebSite","@id":"https:\/\/www.veeva.com\/eu\/#website","url":"https:\/\/www.veeva.com\/eu\/","name":"Veeva Systems Europe","description":"EU Site","inLanguage":"en-US","publisher":{"@id":"https:\/\/www.veeva.com\/eu\/#organization"}}]},"og:locale":"en_US","og:site_name":"Veeva Systems Europe","og:type":"article","og:title":"4 Tips to Streamline Content Review and Approval | Veeva Systems Europe","og:description":"According to Veeva Pulse data, most biopharmas take three weeks to deliver new content to market. At Amylyx, we\u2019ve been focusing on preparing for our drug launch \u2014 and ensuring a strong foundation for content creation that will scale as the company grows has been one of my top priorities.","og:url":"https:\/\/www.veeva.com\/eu\/blog\/4-tips-to-streamline-content-review-and-approval\/","og:image":"https:\/\/www.veeva.com\/eu\/wp-content\/uploads\/2026\/08\/web-default-featured-image-1200x630-2@2x.jpg","og:image:secure_url":"https:\/\/www.veeva.com\/eu\/wp-content\/uploads\/2026\/08\/web-default-featured-image-1200x630-2@2x.jpg","article:published_time":"2022-10-03T10:08:08+00:00","article:modified_time":"2026-02-23T19:31:13+00:00","twitter:card":"summary_large_image","twitter:title":"4 Tips to Streamline Content Review and Approval | Veeva Systems Europe","twitter:description":"According to Veeva Pulse data, most biopharmas take three weeks to deliver new content to market. At Amylyx, we\u2019ve been focusing on preparing for our drug launch \u2014 and ensuring a strong foundation for content creation that will scale as the company grows has been one of my top priorities.","twitter:image":"https:\/\/www.veeva.com\/eu\/wp-content\/uploads\/2026\/08\/web-default-featured-image-1200x630-2@2x.jpg"},"aioseo_meta_data":{"post_id":"66593","title":null,"description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"Article","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"limit_modified_date":false,"open_ai":"{\"title\":{\"suggestions\":[],\"usage\":0},\"description\":{\"suggestions\":[],\"usage\":0}}","created":"2022-09-26 10:05:49","updated":"2026-08-20 15:50:03","focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"ai":null,"breadcrumb_settings":null,"seo_analyzer_scan_date":"2026-08-20 15:50:03"},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/www.veeva.com\/eu\" title=\"Home\">Home<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/www.veeva.com\/eu\/category\/uncategorized\/\" title=\"Uncategorized\">Uncategorized<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t4 Tips to Streamline Content Review and Approval\n<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.veeva.com\/eu"},{"label":"Uncategorized","link":"https:\/\/www.veeva.com\/eu\/category\/uncategorized\/"},{"label":"4 Tips to Streamline Content Review and Approval","link":"https:\/\/www.veeva.com\/eu\/blog\/4-tips-to-streamline-content-review-and-approval\/"}],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/posts\/66593","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/users\/80"}],"replies":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/comments?post=66593"}],"version-history":[{"count":13,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/posts\/66593\/revisions"}],"predecessor-version":[{"id":94658,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/posts\/66593\/revisions\/94658"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/media\/66599"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/media?parent=66593"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/categories?post=66593"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/tags?post=66593"},{"taxonomy":"product","embeddable":true,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/product?post=66593"},{"taxonomy":"area","embeddable":true,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/area?post=66593"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/coauthors?post=66593"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}